Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
47,751,240
-
Share change
-
+4,552,488
-
Total reported value
-
$6,465,099,833
-
Put/Call ratio
-
95%
-
Price per share
-
$135.38
-
Number of holders
-
403
-
Value change
-
+$610,508,007
-
Number of buys
-
194
-
Number of sells
-
178
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2017
As of 31 Mar 2017,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
403 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,751,240 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, VANGUARD GROUP INC, SCOPIA CAPITAL MANAGEMENT LP, STATE STREET CORP, Palo Alto Investors, LLC, AQR CAPITAL MANAGEMENT LLC, AJO, LP, LSV ASSET MANAGEMENT, and GOLDMAN SACHS GROUP INC.
This page lists
404
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.